Pain Management Therapeutic Drugs Market by Indications (Arthritic Pain, Cancer Pain, Chronic Back Pain, Fibromyalgia, Migraine, Neuropathic Pain, and Post-Operative Pain), and Therapeutic Applications (Anesthetics, Anticonvulsants, Antidepressants, Anti-Migraine Agents, NSAIDS, Opioids) and Forecast 2017-2021

Pain Management Therapeutic Drugs Market by Indications (Arthritic Pain, Cancer Pain, Chronic Back Pain, Fibromyalgia, Migraine, Neuropathic Pain, and Post-Operative Pain), and Therapeutic Applications (Anesthetics, Anticonvulsants, Antidepressants, Anti-Migraine Agents, NSAIDS, Opioids) and Forecast 2017-2021

Pain medications are drugs used to relieve discomfort associated with disease, injury, or surgery. Because the pain process is complex, there are many types of pain drugs that provide relief by acting through a variety of physiological mechanisms. Nonsteroidal anti-inflammatory drugs (NSAIDs) act on substances in the body that can cause inflammation, pain, and fever. Corticosteroids exert powerful anti-inflammatory effects. Acetaminophen increases the body’s pain threshold, but it has little effect on inflammation. Opioids, also known as narcotic analgesics, modify pain messages in the brain. Muscle relaxants reduce pain from tense muscle groups, most likely through sedative action in the central nervous system. Anti-anxiety drugs work on pain in three ways: they reduce anxiety, they relax muscles, and they help patients cope with discomfort. Some antidepressants, particularly the tricyclics, may reduce pain transmission through the spinal cord. Some anticonvulsant drugs also relieve the pain of neuropathies, possibly by stabilizing nerve cells.

The global pain management therapeutic drugs market report estimates the market size (Revenue USD million – 2014 to 2021) for key market segments based on the indication (arthritic pain, cancer pain, chronic back pain, fibromyalgia, migraine, neuropathic pain, and post-operative pain), their therapeutic applications (anesthetics, anticonvulsants, antidepressants, anti-migraine agents, NSAIDs, opioids, etc.), and forecasts growth trends (CAGR% – 2017 to 2021).

The global pain management therapeutic drugs market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global pain management therapeutic drugs market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Drugs
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Drug Class or Drug (Brand) Type
    • Drug or Disorder Test
    • Indication Type
    • Drug Treatment
    • Mechanism of Action
    • Therapeutic Area or Nature of Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • IND, NDA filed, FDA, EMEA Approvals
  8. Pipeline Analysis(Phase 1, 2 and 3 Drugs)
    • Phase 3 Drugs Forecast Estimation (Approval to 2025)
    • Phase 1 and 2 Drugs – Qualitative Analysis
  9. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  10. Recommendations
  11. References

Pain Management Therapeutics Market

1. Indication Type
1.1. Arthritic Pain
1.1.1. Osteoarthritis (OA)
1.1.2. Rheumatoid Arthritis (RA)
1.2. Cancer Pain
1.3. Chronic Back Pain
1.4. Fibromyalgia
1.5. Migraine
1.6. Neuropathic Pain
1.7. Post-operative Pain

2. Therapeutic Application
2.1. Anesthetics
2.2. Anticonvulsants
2.3. Antidepressants
2.4. Anti-Migraine Agents
2.5. NSAIDs
2.6. Opioids
2.7. Others

3. Company Profiles
3.1. Abbott Laboratories
3.2. Allergan, Inc.
3.3. Covidien plc
3.4. Durect Corporation
3.5. Eli Lilly and Company
3.6. Endo Health Solutions, Inc.
3.7. Forest Laboratories, Inc.
3.8. GlaxoSmithKline plc.
3.9. Hospira, Inc.
3.10. Johnson & Johnson
3.11. Merck & Co., Inc.
3.12. Mundipharma International Ltd.
3.13. Novartis AG
3.14. NuPathe, Inc.
3.15. Pain Therapeutics, Inc.
3.16. Pfizer, Inc.
3.17. Purdue Pharma L.P.
3.18. QRx Pharma Ltd.
3.19. Sanofi SA
3.20. Teva Pharmaceutical Industries Limited
3.21. Union Chemnique Belge (UCB) S.A.

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*